Completed NCT01888120

Patient Registry of Intrathecal Ziconotide Management(PRIZM)

Patient Registry of Intrathecal Ziconotide Management (PRIZM): An Open-Label, Long Term, Multi-Center, Observational Study of PRIALT® (Ziconotide) Solution, Intrathecal Infusion, in Patients With Severe Chronic Pain

Sponsor: Jazz Pharmaceuticals

Conditions Patients With Severe Chronic Pain

Interventions Ziconotide

Updated 7 times since 2017 Last updated: Mar 14, 2017 Started: Jul 31, 2013 Primary completion: Jan 31, 2017 Completion: Mar 31, 2017

A observational or N/A phase clinical study on Patients With Severe Chronic Pain, this trial is completed. The trial is conducted by Jazz Pharmaceuticals and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Apr 2017 — Apr 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2017 — Apr 2017 [monthly]

Active Not Recruiting NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jazz Pharmaceuticals

Data source: Jazz Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ashland, United States , Atlanta, United States , Batesville, United States , Boise, United States , Carlsbad, United States , Chandler, United States , Charleston, United States , Chino, United States , Clearwater, United States , Clinton Township, United States and 30 more locations